Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M200310200 on June 24, 2002

J. Biol. Chem., Vol. 277, Issue 36, 33338-33343, September 6, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/36/33338    most recent
M200310200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikari, A.
Right arrow Articles by Suketa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikari, A.
Right arrow Articles by Suketa, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Up-regulation of Sodium-dependent Glucose Transporter by Interaction with Heat Shock Protein 70*

Akira IkariDagger, Mika Nakano, Kazuya Kawano, and Yasunobu Suketa

From the Department of Environmental Biochemistry and Toxicology, University of Shizuoka School of Pharmaceutical Sciences, 52-1 Yada, Shizuoka 422-8526, Japan

Received for publication, January 11, 2002, and in revised form, May 21, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Heat shock stress induces some heat shock proteins, including Hsp70, and activates sodium-dependent glucose transport in porcine renal LLC-PK1 cells, but its mechanisms have not been described in detail. We investigated whether sodium-dependent glucose transporter (SGLT1) interacts with Hsp70 to increase SGLT1 activity. Heat shock stress increased SGLT1 activity without changing SGLT1 expression. The increase of SGLT1 activity was completely inhibited by an anti-transforming growth factor-beta 1 (TGF-beta 1) antibody. Instead of heat shock stress, TGF-beta 1 increased SGLT1 activity dose- and time-dependently without changing SGLT1 expression. We found that the amount of Hsp70 immunoprecipitated from TGF-beta 1-treated cells with an anti-SGLT1 antibody was higher than that of the control cells. Transfection of an anti-Hsp70 antibody into the cells inhibited the increase of SGLT1 activity. With confocal laser microscopy, both SGLT1 and Hsp70 was localized near the apical membrane in the TGF-beta 1-treated cells, and an anti-Hsp70 antibody disturbed this localization. Furthermore, we clarified that an anti-Hsp70 antibody inhibited interaction of SGLT1 with Hsp70 in vitro. These results suggest that Hsp70 forms a complex with SGLT1 and increases the expression level of SGLT1 in the apical membrane, resulting in up-regulation of glucose uptake.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Regulation of glucose absorption plays an essential role in maintaining cellular and organic functions. In mammalian, glucose uptake across epithelial cells is mediated via two distinct glucose transporters: the Na+-dependent glucose transporter (SGLT),1 located in the apical membrane, and the facilitative glucose transporter (GLUT), located in the basolateral membrane of kidney (1). The SGLT family includes three homologues: a high-affinity transporter, SGLT1, and low-affinity transporters SGLT2 and SGLT3. LLC-PK1 cells derived from the porcine kidney are a useful model system for investigation of glucose transport because they selectively express SGLT1 and SGLT3 on the apical membrane the same as in vivo (2). Thus far, Rabito and Ausiello (3) have reported that more than 85% of total Na+-dependent glucose uptake in LLC-PK1 cells is mediated via SGLT1.

SGLT1 contains a number of potential protein kinase A and protein kinase C phosphorylation sites (4). The expression level of SGLT1 protein on plasma membrane was mainly regulated by these two kinases; protein kinase A increased the number of SGLT1 in the plasma membrane, whereas protein kinase C decreased it in SGLT1-expressed Xenopus oocytes (5). Furthermore, it has been reported that protein kinase C lowered the turn-over rate in SGLT1-expressed COS-7 cells (6). The stabilization of SGLT1 in the plasma membrane is an important step toward increasing glucose uptake.

Stress- or injury-induced protection and functional enhancement are often associated with increased synthesis and accumulation of heat shock proteins, particularly Hsp70 (for review, see Refs. 7-9). Hsp70 has a role in preventing the aggregation and misfolding of proteins. However, it plays an essential role under normal condition, including assisting in the folding of newly synthesized proteins, translocating proteins to the appropriate organs, and dissociating protein aggregates. In addition, Hsp70 interacts with specific native proteins expressed on plasma membrane, such as A1 adenosine receptor (10), Na+/H+-exchanger (11), and Na+,K+-ATPase (12).

Hsp70 is present ubiquitously in all renal tubular epithelial cells (13). During cellular recovery from renal ischemia, Hsp70 interacts with cytoskeletal elements (12). In LLC-PK1 cells, it has been reported that heat shock stress increases Hsp70 and SGLT1 activity, and mild heat shock stress protects the cell from injury (14). It is, however, unclear what mechanism is involved in the increase of SGLT1 activity. In the present study, we have shown that heat shock stress increases SGLT1 activity mediated via the production of transforming growth factor-beta 1 (TGF-beta 1). Furthermore, we found that TGF-beta 1 increases the interaction of SGLT1 with Hsp70, resulting in the increase of SGLT1 activity.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- A mouse monoclonal antibody raised Hsp70 (SPA-810) was purchased from StressGen Biotechnologies. A rabbit polyclonal antibody raised actin (C-11) and a goat polyclonal antibody raised against aminopeptidase N were from Santa Cruz Biotechnology. A rabbit polyclonal antibody raised Hsp70 was from Upstate Biotechnology. This antibody was used in the experiments of transfection and interaction of SGLT1 with Hsp70 in vitro. A rabbit polyclonal antibody raised against porcine SGLT1 was kindly provided by Prof. Julie E. Lever (University of Texas Medical School, Houston). Fluorescein isothiocyanate (FITC)-labeled anti-mouse IgG was from American Qualex. Texas Red-labeled anti-rabbit IgG was from EY Laboratories. AMCA-labeled anti-goat IgG was from Jackson ImmunoResearch Laboratories. A porcine TGF-beta 1 was from Wako Pure Chemicals (Osaka, Japan). Chariot, a transfection reagent capable of delivering antibodies was from Active Motif. Protein G-Sepharose beads were from Amersham Biosciences. [14C]Methyl alpha -glucopyranoside was from PerkinElmer Life Sciences. All other regents were of the highest grade of purity available.

Cell Culture-- Porcine renal epithelial LLC-PK1 cells were obtained from JCRB (Tokyo, Japan). Cells were maintained in Medium 199 (Sigma) supplemented with 10% fetal calf serum (FCS), 100 µg/ml penicillin, and 100 µg/ml streptomycin in an atmosphere of 5% CO2 in air at 37 °C.

Measurement of SGLT1 Activity-- Cells were grown to subconfluent or confluent conditions on 24-well plates and then treated with heat shock stress or TGF-beta 1 in FCS-free Medium 199. Heat shock stress was performed at 42 °C for 3 h and then at 37 °C for 12 h. TGF-beta 1 was added in FCS-free Medium 199 at the indicated times and concentrations. The SGLT1 activity was assayed by incubating in a Hanks' balanced salt solution containing [14C]methyl alpha -glucopyranoside (0.4 µCi/ml), 137 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2 and 10 mM HEPES, pH 7.4 in the presence and absence of phloridzin (0.5 mM), a potent SGLT1 inhibitor. After incubation at 37 °C for 30 min, the solution was aspirated quickly and washed by ice-cold Hanks' balanced salt solution without [14C]methyl alpha -glucopyranoside for 4 times. The cells were solubilized with 0.5 N NaOH and the aliquots were taken for determination of radioactivity and protein concentration. Protein concentration was measured using the protein assay kit (Bio-Rad) with bovine serum albumin as the standard.

Preparation of Membrane Fraction from LLC-PK1 Cells-- Whole membrane fraction was prepared from the cells cultured in 10-cm Petri dishes by the procedure of Peng and Lever (15). In brief, cells were washed three times with Hanks' balanced salt solution, scraped, and suspended in PBS containing 5 mM EDTA. After centrifugation at 80 × g for 5 min, the pellet was solubilized in 20 mM Tris-HCl, sonicated, and centrifuged at 1,000 × g for 5 min. The supernatant was centrifuged at 100,000 × g for 60 min, and the pellet was suspended in 20 mM Tris-HCl (membrane fraction).

SDS-Polyacrylamide Gel Electrophoresis and Western Blotting-- SDS-polyacrylamide gel electrophoresis was carried out as described previously (16). In brief, membrane preparations (20 µg) were applied to the SDS-polyacrylamide gel. Proteins were blotted onto a polyvinylidene difluoride membrane and incubated for 1.5 h with each primary antibody followed by peroxidase-conjugated anti-rabbit IgG or mouse IgG. Finally, the blots were stained with the ECL Western blotting kit from Amersham Biosciences.

Immunoprecipitation-- The apical membrane fraction prepared as described elsewhere (17). The samples solubilized in a lysis buffer containing 1% Triton X-100, 150 mM NaCl, 0.5 mM EDTA, and 50 mM Tris-HCl, pH 8.0, were incubated with protein G-Sepharose beads and an antibody specific for the SGLT1 at 4 °C for 1 h with gentle rocking. After centrifugation at 6,000 × g for 1 min, the pellet was washed four times with a lysis buffer. The pellet was solubilized in a sample buffer for SDS-polyacrylamide gel electrophoresis. The Western blotting was carried out as described above.

Transfection of Antibodies-- Cells were grown to confluence on 24-well plate. A polyclonal antibody raised Hsp70 or an anti-rabbit IgG were transfected into the cells using a Chariot kit according to the appended protocol. After 3 h of transfection, the cells were treated with TGF-beta 1 followed by examining SGLT1 activity and localization of both SGLT1 and Hsp70.

Immunocytochemistry-- The cells grown on cover glass were incubated with FCS-free Medium 199 in the presence and absence of TGF-beta 1 and washed twice with PBS supplemented with 1 mM CaCl2 and 1 mM MgCl2 prior to fixation with 3% paraformaldehyde for 7 min at room temperature. The cells were then permeabilized with 0.3% Triton X-100 for 15 min and 5% goat serum in PBS (blocking solution) for 30 min. Incubation with anti-SGLT1, anti-Hsp70, and aminopeptidase N antibodies (final dilution 1/120) for 90 min at room temperature was followed by washes with PBS and then incubation for 90 min with Texas Red-labeled anti-rabbit IgG combined with anti-SGLT1 antibody, FITC-labeled anti-mouse IgG combined with anti-Hsp70 antibody, and AMCA-labeled anti-goat IgG combined with anti-aminopeptidase N antibody in a blocking solution (dilution 1/20). Immunolabeled cells were visualized on a LSM 510 confocal microscope (Carl Zeiss) set with the appropriate filter for FITC (488 nm excitation, 530 nm emission filter), Texas Red (543 nm excitation, 585-615 nm emission filter), and AMCA detection (351 nm excitation, 450 nm emission filter). Images were collected at 1.0-µm increments (vertical direction) beginning at the apical membrane and ending at the basal membrane. Images were further processed using Adobe Photoshop (Adobe System, Inc).

Complex Formation of SGLT1 with Hsp70 in Vitro-- The apical membrane fraction was prepared from TGF-beta 1 (2 ng/ml, 2 h)-treated cells. The sample was preincubated with 5 mM ATP/10 mM Mg2+ at 30 °C for 10 min and then incubated with lysis buffer containing hexokinase (50 units/ml) and 15 mM glucose at 30 °C for 10 min to remove ATP from the incubation solution (18). The aliquot was incubated with protein G-Sepharose beads at 4 °C for 1 h with gentle rocking. After centrifugation at 6,000 × g for 1 min, the supernatant was incubated with the mixture of new beads and an antibody for SGLT1 at 4 °C for 12 h to immunoprecipitate proteins specifically interacting with SGLT1. After centrifugation, the pellet was solubilized in a sample buffer, and then SDS-polyacrylamide gel electrophoresis and Western blotting were carried out as described above.

Statistics-- The results are presented as the means ± S.E. Differences between groups were analyzed by one-way analysis of variance, and correction for multiple comparison was made using Tukey's multiple comparison test. Statistically significant differences were assumed at p < 0.05.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Expression of SGLT1 and Hsp70 in LLC-PK1 Cells-- LLC-PK1 cells were utilized to examine the expression of SGLT1 and glucose absorption in renal proximal tubule. In this cell line, SGLT1 activity has been observed to develop after cell confluence (2, 19). First, we checked the expressions of SGLT1 and Hsp70 in the different growing stages (Fig. 1A). Hsp70 was detected in both subconfluent and confluent conditions, but SGLT1 was not detected in the subconfluent condition. As a sample loading control, we observed that actin exists in the same amount in both the confluent and subconfluent conditions (data not shown). To confirm the expression pattern of SGLT1, we measured SGLT1 activity using [14C]methyl alpha -glucopyranoside. SGLT1 activity was observed in the confluent condition but not in the subconfluent condition (Fig. 1B). This result was coincident with the expression pattern of SGLT1 (Fig. 1A).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   Expression and transport activity of SGLT1 in subconfluent and confluent LLC-PK1 cells. A, membrane fractions were prepared from subconfluent and confluent cells. Samples were run on SDS-PAGE and immunoblotted with an anti-SGLT1 antibody (SGLT1) or an anti-Hsp70 antibody (Hsp70). B, SGLT1 activity was determined by [14C]AMG uptake carried out at 37 °C for 30 min in subconfluent (open column) and confluent cells (closed column). **, significantly different from the subconfluent condition (p < 0.01); n = 4.

Neutralization of Heat Shock Response by an Anti-TGF-beta 1 Antibody-- In the confluent condition, heat shock stress increased SGLT1 activity that is neutralized by anti-TGF-beta 1 antibody (Fig. 2A). Interestingly, Hsp70 expression was potently increased by heat shock stress, but SGLT1 was unchanged (Fig. 2B). An anti-TGF-beta 1 antibody scarcely affected the expression of SGLT1 and Hsp70. These results indicate that heat shock stress increases SGLT1 activity mediated via production of TGF-beta 1, and the inhibition of SGLT1 activity by an anti-TGF-beta 1 antibody is not caused by the decrease of SGLT1 expression. Next, we examined the regulatory mechanism of SGLT1 activity by TGF-beta 1.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of an anti-TGF-beta 1 antibody on the heat shock response. A, heat shock stress was tested at 42 °C for 3 h (closed columns) followed by incubation at 37 °C for 12 h. During these incubations, the media contained an anti-TGF-beta 1 antibody (0.1, 1, and 10) or did not contained the antibody (N). Instead of heat shock, control cells were incubated continuously at 37 °C (open column). Then, SGLT1 activity was determined at 37 °C for 30 min (n = 5-6). B, heat shock stress (HS) was tested in the absence (-) or presence (+) of an anti-TGF-beta 1 antibody (10 µg/ml). Control cells were incubated continuously at 37 °C (left lane). Then each membrane fraction was collected, run on SDS-PAGE, and immunoblotted with an anti-SGLT1 antibody or an anti-Hsp70 antibody.

Effects of TGF-beta 1 on SGLT1 Activity and Expression-- TGF-beta 1 increased SGLT1 activity in a time-dependent manner, and the maximal effect was observed at 2 h (Fig. 3A). The effect of TGF-beta 1 (0.05-20 ng/ml) was dose-dependent, and the EC50 was 2 ng/ml (Fig. 3B). It has been reported that TGF-beta 1 increases glucose uptake by enhancing GLUT1 expression in mesangial cells (20, 21). Therefore, we checked the expression level of SGLT1. TGF-beta 1 did not significantly increase SGLT1 expression compared with control (Fig. 4A). Furthermore, heat shock stress increased Hsp70 expression, but TGF-beta 1 did not change it. Taken together, the increase of Hsp70 expression was not involved in the up-regulation of SGLT1 activity. So far, it has been reported that Hsp70 and related proteins interact with plasma membrane proteins such as Na+/H+-exchanger (11), Na+/K+-ATPase (12), as well as the cystic fibrosis transmembrane conductance regulator (22). Next, we examined the interaction level of SGLT1 with Hsp70. Membrane fractions prepared from control and TGF-beta 1-treated cells were immunoprecipitated with an anti-Hsp70 or an anti-SGLT1 antibody. Then, each sample was reacted with an anti-SGLT1 antibody or an anti-Hsp70 antibody, respectively. As shown in Fig. 4B, TGF-beta 1 increased the interaction of SGLT1 with Hsp70.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Increase of SGLT1 activity by TGF-beta 1. A, LLC-PK1 cells were incubated with 2 ng/ml TGF-beta 1 for the indicated time, and then SGLT1 activity was determined (n = 3-4). B, the cells were incubated with TGF-beta 1 at the indicated concentration for 2 h, and then SGLT1 activity was determined (n = 3-4).


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 4.   Comparison of SGLT1 and Hsp70 expression levels. A, the membrane fractions were prepared from control cells (-) and 2 ng/ml TGF-beta 1-treated (+) cells. Samples were run on SDS-PAGE and immunoblotted with an anti-SGLT1 (SGLT1) or an anti-Hsp70 antibody (Hsp70). B, the membrane fractions prepared from control (-) and TGF-beta 1-treated (+) cells were immunoprecipitated with an anti-Hsp70 (left) or an anti-SGLT1 antibody (right) and then immunoblotted with an anti-SGLT1 or an anti-Hsp70 antibody, respectively.

Localization of SGLT1 and Hsp70-- We determined the localization of SGLT1 and Hsp70 by immunocytochemistry (Fig. 5A). Aminopeptidase N, an apical membrane marker protein, appeared as blue fluorescence only in the apical membrane site. Hsp70, which appeared as green fluorescence, was localized in the entire plasma membrane and cytosol fraction. SGLT1 appeared as red fluorescence. The image of SGLT1 merged with that of aminopeptidase N showed an intermediate color of purple in the TGF-beta 1-treated cells, indicating that SGLT1 and aminopeptidase N were co-localized near the apical membrane site (Fig. 5A, upper panels). Furthermore, co-localization of SGLT1 and Hsp70, appearing as yellow, was moved from the cytosol fraction to the apical membrane site by TGF-beta 1 (Fig. 5A, lower panels). Next, we examined the effect of an anti-Hsp70 antibody on the localization of SGLT1 and Hsp70. Transfection of an anti-Hsp70 antibody into the cells using a Chariot kit inhibited the TGF-beta 1-induced movement of SGLT1 and Hsp70 to the apical membrane site (Fig. 5B, right). In control cells, an anti-rabbit IgG did not affect co-localization of SGLT1 and Hsp70 (Fig. 5B, left).


View larger version (50K):
[in this window]
[in a new window]
 
Fig. 5.   Effects of an anti-Hsp70 antibody on SGLT1 and Hsp70 localization. A, the cells were treated with anti-SGLT1, anti-Hsp70, and anti-aminopeptidase N antibodies. Images of confocal microscope (x-z axis) showed localization of SGLT1 (red), Hsp70 (green), and aminopeptidase N (blue) in control cells and in 2 ng/ml TGF-beta 1-treated cells. AP, apical membrane site; BL, basal membrane site. B, the cells were transfected with 1.8 µg/ml anti-mouse IgG or 1.8 µg/ml anti-Hsp70 antibody (Hsp70) using a Chariot kit followed by incubation with 2 ng/ml TGF-beta 1. The merging colors showed the co-localization of aminopeptidase N with SGLT1 (purple) and Hsp70 with SGLT1 (yellow). Scale bar, 10 µm.

Inhibition of SGLT1 Activity by an Anti-Hsp70 Antibody-- In the rat-1 fibroblasts overexpressing human insulin receptors, microinjection of an anti-Hsp70 antibody into the cells partially inhibited insulin-stimulated mitogenesis (23). To examine the necessity of the interaction of SGLT1 with Hsp70 in the elevation of SGLT1 activity, we examined the effect of an anti-Hsp70 antibody on SGLT1 activity. This antibody (1.8 µg/ml) inhibited TGF-beta 1-elicited SGLT1 activation and slightly inhibited basal SGLT1 activity (Fig. 6). This inhibitory effect on SGLT1 activity corresponds to localization of SGLT1 and Hsp70. In control cells, an anti-rabbit IgG (1.8 µg/ml) did not inhibit TGF-beta 1-elicited SGLT1 activation. These results indicate that interaction of SGLT1 with Hsp70 induces an elevation of SGLT1 activity.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Effects of an anti-Hsp70 antibody on SGLT1 activity. LLC-PK1 cells were transfected with an anti-Hsp70 antibody (1.8 µg/ml) using Chariot. Then, the cells were incubated without (open column) or with 2 ng/ml TGF-beta 1 at 37 °C for 2 h (closed columns). An anti-rabbit IgG (1.8 µg/ml) was transfected into the control cells (N) instead of an anti-Hsp70 antibody; n = 3-4. **, significantly different from the value in the absence of an anti-Hsp70 antibody (p < 0.01).

Interaction of SGLT1 with Hsp70 in Vitro-- Hsp70 and its related protein bind specifically to hydrophobic peptide segments in an ATP-dependent manner (24). We examined whether SGLT1 interacts with Hsp70 in vitro (Fig. 7). Hsp70 was immunoprecipitated with an anti-SGLT1 antibody in the absence of ATP. After incubation of the apical membrane fraction with ATP (5 mM), Hsp70 dissociated from SGLT1. Interestingly, the removal of ATP by hexokinase and glucose induced a re-interaction of Hsp70 with SGLT1. This interaction was inhibited by an anti-Hsp70 antibody but not by a anti-rabbit IgG. We detected no band in the membrane that was not incubated with an anti-Hsp70 antibody (data not shown), indicating an anti-Hsp70 antibody did not contaminate the samples. The interaction of Hsp70 with SGLT1 corresponds to the co-localization data shown in Fig. 6.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 7.   Effects of ATP on interaction between SGLT1 and Hsp70 in vitro. The membrane fractions were prepared from 2 ng/ml TGF-beta 1-treated cells and then preincubated in the absence (-) or presence (+) of 5 mM ATP/10 mM Mg2+ at 30 °C for 10 min. As indicated, the samples were incubated with lysis buffer containing hexokinase (50 units/ml) and 15 mM glucose in the presence of an anti-Hsp70 antibody (1.8 µg/ml) or an anti-rabbit IgG (1.8 µg/ml) at 30 °C for 10 min. Finally, the samples were incubated with a mixture of protein G-Sepharose and an anti-SGLT1 antibody at 4 °C for 12 h in order to collect proteins interacted with SGLT1. The immunoprecipitated protein was detected with anti-Hsp70 antibody.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The mRNA and transport activity of SGLT1 are not detectable in subconfluent LLC-PK1 cells as shown by Northern blotting and glucose transport assay (2, 19, 24). We also showed that SGLT1 protein did not express in the subconfluent condition and that SGLT1 protein and activity appeared only in the confluent condition (Fig. 1). On the contrary, Hsp70 expressed in both the subconfluent and the confluent conditions. Hsp70 and related proteins play an essential role under normal physiological condition, including assisting in the folding of newly synthesized proteins, translocating proteins to the appropriate organs, and dissociating protein aggregates (7-9). So far, mammalian Hsp70 has been reported to interact with some transporters expressed in epithelial plasma membrane to maintain their functions (10-12). However, there is no report on whether Hsp70 interacts with SGLT1 and is involved in the regulation of SGLT1 activity.

Heat shock, oxidants, tissue trauma, and hormonal stimulation increase the expression of Hsp70 and related proteins. Some stresses induce the production of TGF-beta 1, a multifunctional cytokine, which transmits various cellular responses such as cell proliferation and formation of the extracellular matrix (25-30). Interestingly, the release of TGF-beta 1 increased in LLC-PK1 cells developing after cell confluence (29). Our results indicate that heat shock stress increases SGLT1 activity mediated via production of TGF-beta 1 (Fig. 2A). TGF-beta receptors are divided into three types; type I (53 kDa), type II (70-85 kDa), and type III (250-350 kDa) (30). The signal is primarily through the TGF-beta type II receptor, and then phosphorylation of type I receptor activates protein kinases. TGF-beta 1 has been reported to stimulate adenylate cyclase activity quickly in LLC-PK1 cells (31). Activation of protein kinase A up-regulates SGLT1 mRNA level after a 2-4-day lag period, accompanied by pronounced stabilization of the message (15). In the present study, heat shock stress did not significantly increase the expression level of SGLT1 protein within 12 h (Fig. 2B). We suggest that heat shock stress induces SGLT1 activation without increasing SGLT1 expression in the short term.

TGF-beta 1 increased SGLT1 activity but did not change the expression levels of SGLT1 and Hsp70 (Figs. 3 and 4). An anti-TGF-beta 1 antibody inhibited SGLT1 activation induced by heat shock stress but had no effect on the Hsp70 expression (Fig. 2). These results suggest that the increase of Hsp70 is independent of the regulation of SGLT1 activity and is not an important phenomenon in up-regulating SGLT1 activity. Recently, Bidmon et al. (12) reported that the interaction of Hsp70 with Na+/K+-ATPase is increased following stabilization of Na+/K+-ATPase within the cytoskeletal fraction during the restoration of the renal cells after ischemia. We found that SGLT1 interacts with Hsp70 under normal conditions and TGF-beta 1 increases the interaction level between them (Fig. 4B).

We hypothesized that the interaction of SGLT1 with Hsp70 and the localization of these proteins in the apical membrane site are important in increasing SGLT1 activity. As determined by immunocytochemistry, TGF-beta 1 made move both SGLT1 and Hsp70 near the apical membrane site (Fig. 5A). Furthermore, an anti-Hsp70 antibody inhibited the co-localization of SGLT1 and Hsp70 in TGF-beta 1-treated cells (Fig. 5B). Transfection of an anti-Hsp70 antibody inhibited the elevation of SGLT1 activity elicited by TGF-beta 1 (Fig. 6). These results suggest that translocation of Hsp70 from the cytosol to the apical membrane site is important in stabilizing SGLT1 expression on the membrane and up-regulating glucose uptake.

To confirm the interaction of SGLT1 with Hsp70, we performed immunoprecipitation assay in vitro. Hsp70 and its related protein bind specifically to hydrophobic peptide segments that are not conserved, in an ATP-dependent manner (32). The ADP-bound form of Hsp70 has a high affinity for peptides, whereas the ATP form has a low affinity. ATP dissociated Hsp70 from SGLT1 in the apical membrane fraction (Fig. 7). The removal of ATP induced a re-interaction of these proteins. Furthermore, an anti-Hsp70 antibody inhibited the interaction in vitro similar to what is shown in Fig. 5B. These results indicate that Hsp70 interacts with SGLT1 in an ATP-dependent manner. Furthermore, an anti-Hsp70 antibody blocked interaction of these proteins, leading to inhibition of SGLT1 activity.

In conclusion, we found that heat shock stress increased SGLT1 activity mediated via TGF-beta 1 production. However, the treatment of the cells with heat shock stress or TGF-beta 1 for short periods did not increase SGLT1 expression. TGF-beta 1 increased the interaction of SGLT1 with Hsp70 and translocated them near the apical membrane. These results suggest that Hsp70 supports the apical localization and function of SGLT1 under both normal and restorative conditions after injury with heat shock stress.

    ACKNOWLEDGEMENTS

We thank Prof. J. E. Lever (University of Texas Medical School, Houston) for providing a rabbit polyclonal antibody raised porcine SGLT1.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 81-54-264-5674; Fax: 81-54-264-5672; E-mail: ikari@u-shizuoka-ken.ac.jp.

Published, JBC Papers in Press, June 24, 2002, DOI 10.1074/jbc.M200310200

    ABBREVIATIONS

The abbreviations used are: SGLT, sodium-dependent glucose transporter; GLUT, glucose transporter; TGF, transforming growth factor; FITC, fluorescein isothiocyanate; AMCA, 7-amino-4-methylcoumarin-3-acetic acid; FCS, fetal calf serum; PBS, phosphate-buffered saline; Hsp70, heat shock protein 70.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Hediger, M. A., and Rhoads, D. B. (1994) Physiol. Rev. 74, 993-1026[Free Full Text]
2. Mullin, J. M., Weibel, J., Diamond, L., and Kleinzeller, A. (1980) J. Cell. Physiol. 104, 375-389[CrossRef][Medline] [Order article via Infotrieve]
3. Rabito, C. A., and Ausiello, D. A. (1980) J. Membr. Biol. 54, 31-38[CrossRef][Medline] [Order article via Infotrieve]
4. Turk, E., Kerner, C. J., Lostao, M. P., and Wright, E. M. (1996) J. Biol. Chem. 271, 1925-1934[Abstract/Free Full Text]
5. Hirsch, J. R., Loo, D. D. F., and Wright, E. M. (1996) J. Biol. Chem. 271, 14740-14746[Abstract/Free Full Text]
6. Vayro, S., and Silverman, M. (1999) Am. J. Physiol. 276, C1053-C1060[Abstract/Free Full Text]
7. Hartl, F. U. (1996) Nature 381, 571-580[CrossRef][Medline] [Order article via Infotrieve]
8. Bukau, B., and Horwich, A. L. (1998) Cell 92, 351-366[CrossRef][Medline] [Order article via Infotrieve]
9. Beck, F.-X., Neuhofer, W., and Muller, E. (2000) Am. J. Physiol. 279, F203-F215
10. Sarrio, S., Casado, V., Escriche, M., Ciruela, F., Mallol, J., Canela, E. I., Lluis, C., and Franco, R. (2000) Mol. Cell. Biol. 20, 5164-5174[Abstract/Free Full Text]
11. Silva, N. L. C. L., Haworth, R. S., Singh, D., and Fliegel, L. (1995) Biochemistry 34, 10412-10420[CrossRef][Medline] [Order article via Infotrieve]
12. Bidmon, B., Endemann, M., Muller, T., Arbeiter, K., Herkner, K., and Aufricht, C. (2000) Kidney Int. 58, 2400-2407[CrossRef][Medline] [Order article via Infotrieve]
13. Muller, E., Neuhofer, W., Ohno, A., Rucker, S., Thurau, K., and Beck, F.-X. (1996) Pflugers Arch. Eur. J. Physiol. 431, 608-617[Medline] [Order article via Infotrieve]
14. Sussman, C. R., and Renfro, J. L. (1997) Am. J. Physiol. 42, F530-F537
15. Peng, H., and Lever, J. E. (1995) J. Biol. Chem. 270, 20536-20542[Abstract/Free Full Text]
16. Ikari, A., Nakajima, K., Kawano, K., and Suketa, Y. (2001) Biochim. Biophys. Res. Commun. 287, 671-674[CrossRef][Medline] [Order article via Infotrieve]
17. Turner, R. J., and Moran, A. (1982) Am. J. Physiol. 242, F406-F414
18. Oiwa, K., Kawakami, T., and Sugi, H. (1993) J. Biochem. 114, 28-32[Abstract/Free Full Text]
19. Shioda, T., Ohta, T., Isselbacher, K. J., and Rhoads, D. B. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11919-11923[Abstract/Free Full Text]
20. Heilig, C. W., Liu, Y., England, R. L., Freytag, S. O., Gilbert, J. D., Heilig, K. O., Zhu, M., Concepcion, L. A., and Brosius, F. C. (1997) Diabetes 46, 1030-1039[Abstract]
21. Inoki, K., Haneda, M., Maeda, S., Koya, D., and Kikkawa, R. (1999) Kidney Int. 55, 1704-1712[CrossRef][Medline] [Order article via Infotrieve]
22. Choo-Kang, L. R., and Zeitlin, P. L. (2001) Am. J. Physiol. 281, L58-L68[Abstract/Free Full Text]
23. Takata, Y., Imamura, T., Iwata, M., Usui, I., Haruta, T., Nandachi, N., Ishiki, M., Sasaoka, T., and Kobayashi, M. (1997) Biochim. Biophys. Res. Commun. 237, 345-347[CrossRef][Medline] [Order article via Infotrieve]
24. Yet, S. F., Kong, C. T., Peng, H., and Lever, J. E. (1994) J. Cell. Physiol. 158, 506-512[CrossRef][Medline] [Order article via Infotrieve]
25. Cao, Y., Ohwatari, N., Matsumoto, T., Kosaka, M., Ohtsuru, A., and Yamashita, S. (1999) Pflugers Arch. Eur. J. Physiol. 438, 239-244[CrossRef][Medline] [Order article via Infotrieve]
26. Battegay, E. J., Raines, E. W., Seifert, R. A., Bowen-Pope, D. F., and Ross, R. (1990) Cell 63, 515-524[CrossRef][Medline] [Order article via Infotrieve]
27. Sharma, K., and Ziyadeh, F. N. (1995) Diabetes 44, 1139-1146[Abstract]
28. Weber, H., Wagner, A. C., Jonas, L., Merkord, J., Hofken, T., Nizze, H., Leitzmann, P., Goke, B., and Schuff-Werner, P. (2000) Dig. Dis. Sci. 45, 2252-2264[CrossRef][Medline] [Order article via Infotrieve]
29. Phillips, A. O., Steadman, R., Morrisey, K., and Williams, J. D. (1997) Am. J. Pathol. 150, 1101-1111[Abstract]
30. Massague, J. (1992) Cell 69, 1067-1070[CrossRef][Medline] [Order article via Infotrieve]
31. Anderson, R. J., Sponsel, H. T., Breckon, R., Marcell, T., and Hoeffler, J. P. (1993) Am. J. Physiol. 265, F584-F591[Abstract/Free Full Text]
32. Flynn, G. C., Pohl, J., Flocco, M. T., and Rothman, J. E. (1991) Nature 353, 726-730[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Balen, M. Ljubojevic, D. Breljak, H. Brzica, V. Zlender, H. Koepsell, and I. Sabolic
Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C475 - C489.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
A. R. A. Villalobos and J. L. Renfro
Trimethylamine oxide suppresses stress-induced alteration of organic anion transport in choroid plexus
J. Exp. Biol., February 1, 2007; 210(3): 541 - 552.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Garriga, R. R. Hunter, C. Amat, J. M. Planas, M. A. Mitchell, and M. Moreto
Heat stress increases apical glucose transport in the chicken jejunum
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R195 - R201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Kimura, J. R. Turner, D. A. Braasch, and R. K. Buddington
Lumenal adenosine and AMP rapidly increase glucose transport by intact small intestine
Am J Physiol Gastrointest Liver Physiol, December 1, 2005; 289(6): G1007 - G1014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Ikari, N. Hirai, M. Shiroma, H. Harada, H. Sakai, H. Hayashi, Y. Suzuki, M. Degawa, and K. Takagi
Association of Paracellin-1 with ZO-1 Augments the Reabsorption of Divalent Cations in Renal Epithelial Cells
J. Biol. Chem., December 24, 2004; 279(52): 54826 - 54832.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Khoursandi, D. Scharlau, P. Herter, C. Kuhnen, D. Martin, R. K. H. Kinne, and H. Kipp
Different modes of sodium-D-glucose cotransporter-mediated D-glucose uptake regulation in Caco-2 cells
Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1041 - C1047.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. E. Zachara, N. O'Donnell, W. D. Cheung, J. J. Mercer, J. D. Marth, and G. W. Hart
Dynamic O-GlcNAc Modification of Nucleocytoplasmic Proteins in Response to Stress: A SURVIVAL RESPONSE OF MAMMALIAN CELLS
J. Biol. Chem., July 16, 2004; 279(29): 30133 - 30142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. L. E. Walgren, T. S. Vincent, K. L. Schey, and M. G. Buse
High glucose and insulin promote O-GlcNAc modification of proteins, including alpha -tubulin
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E424 - E434.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/36/33338    most recent
M200310200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikari, A.
Right arrow Articles by Suketa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikari, A.
Right arrow Articles by Suketa, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement